Obermatt
See Similar Stocks →

Akso Health Group

NAQ:AHG · US98422P1084
Health Care Providers & ServicesSmall

360

2
Medium confidence — indicative
Profit price71
Owner Earnings Yield1
Dividend Yield1
Price/Sales40
EV / Gross Profit1
Price/Book9
Return on Capital12
Cash Return on Capital1
Return on Equity1
EBIT Margin3
Gross Profitability1
Accruals1
Owner Earnings Margin1
Sales growth42
Profit growth55
Reinvestment63
Price momentum47
Debt load95
Refinancing44
Debt Payback1
Liquidity19
Analyst ratings—
Expectations trend—
Market mood5
Value Creation2/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Akso Health Group doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
TypePublic Company
ExchangeNASDAQCM
Founded2016
Employees3
Websiteahgtop.com/en/index.html
ISINUS98422P1084
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Health DiagnosticsChronic DiseasesLifestyleDigital WellnessMHealthWearablesOncologyBankingConsumer LendingCreditFinanceFinancial ServicesMarketplaceVenture Capital

Description

Akso Health Group (Akso) focuses on exploring other area of healthcare sector other than the medical devices and supplies. Recently, the company advanced its presence in the online hospital and chain pharmacy segments in China. In November 2024, the…

Analysis

Story stock

Akso Health Group is a story stock: the narrative is ambitious and the price reflects it, but the underlying numbers are weak.

Valuation data is not available for this company.

The trajectory is mixed and the balance sheet is stretched. The company scores 2/20 on our value-creation score: not creating value. Analyst sentiment is cautious.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
17
2026

All-time high

19

Mar 2026

All-time low

17

Jun 2026

Average rank

18

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
40
—
—
—
Price/Earnings
100
—
—
—
Price/Book
9
—
—
—
Dividend Yield
1
—
—
—
Value (overall)
10
—
—
—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Akso Health Group with its peers
Prenetics Global
NMQ:PRE
52
CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Australian Clinical Labs
ASX:ACL
65
CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
Full Stock Analysis →
Innovent Biologics
HKG:1801
68
CountryChina
IndustryBiotechnology
SizeLarge
Full Stock Analysis →
H.U. Group Holdings
TYO:4544
83
CountryJapan
IndustryHealth Care Providers & Services
SizeLarge
Full Stock Analysis →
Takaras
TYO:2531
28
CountryJapan
IndustryBeverages
SizeLarge
Full Stock Analysis →
Mesoblast
ASX:MSB
42
CountryAustralia
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →